đđIn 2025, global life expectancy remains one of the most uneven indicators of development. According to UN projections, the gap between the longest- and shortest-living nations exceeds 30 years. Monaco leads with a life expectancy of 90 years, followed by Japan (85), Singapore (84), and France (84). The U.S. trails developed peers with 80, despite spending 17.3% of its GDP on healthcare â far more than any other nation.
At the opposite end, countries like Nigeria (56), Chad (55), and Somalia (56) illustrate how fragile infrastructure, high infant mortality, AIDS, and violent conflict suppress lifespans. Africa remains structurally disadvantaged: despite accounting for ~18% of global population, the continent lags in both medical access and economic growth, limiting health system expansion.
Meanwhile, the demographic epicenter of the developed world is aging. By 2030, over 21% of the EU and Japan will be aged 65+, creating long-term stress on pension systems, labor markets, and savings behavior. Investors and policymakers increasingly look to biotech, AI-driven health diagnostics, and longevity-focused therapeutics as solutions â and investment frontiers.
For markets, this isnât just a social issue â itâs an allocation one. As global life expectancy increases, expect shifts in capital toward healthcare tech, private pensions, and aging-friendly urban infrastructure. Countries that fail to adapt demographically may face economic underperformance.
How will global capital flows adapt to an aging yet increasingly unequal world â and which regions will best monetize the longevity revolution?#AMAGE
